Utilizing 34,348 SARS CoV-2 NAAT results from two health systems, we estimated the clinical sensitivity of a single SARS CoV-2 NAAT. We found that SARS CoV-2 NAAT has 82-97% sensitivity for diagnosing COVID-19 among symptomatic patients.
CITATION STYLE
Ridgway, J. P., Pisano, J., Landon, E., Beavis, K. G., & Robicsek, A. (2020). Clinical Sensitivity of SARS-CoV-2 Nucleic Acid Amplification Tests for Diagnosing COVID-19. Open Forum Infectious Diseases. https://doi.org/10.1093/ofid/ofaa315
Mendeley helps you to discover research relevant for your work.